Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures.
Spigel DR, Burris HA 3rd, Greco FA, Shih KC, Gian VG, Lipman AJ, Daniel DB, Waterhouse DM, Finney L, Heymach JV, Hainsworth JD. Spigel DR, et al. Among authors: finney l. Cancer. 2018 Jun 1;124(11):2355-2364. doi: 10.1002/cncr.31290. Epub 2018 Apr 12. Cancer. 2018. PMID: 29645086 Free article. Clinical Trial.
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
Yardley DA, Young RR, Adelson KB, Silber AL, Najera JE, Daniel DB, Peacock N, Finney L, Hoekstra SJ, Shastry M, Hainsworth JD, Burris HA. Yardley DA, et al. Among authors: finney l. Clin Breast Cancer. 2022 Apr;22(3):269-278. doi: 10.1016/j.clbc.2021.10.011. Epub 2021 Oct 28. Clin Breast Cancer. 2022. PMID: 34824002 Clinical Trial.
Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute.
Hainsworth JD, Thompson DS, Bismayer JA, Gian VG, Merritt WM, Whorf RC, Finney LH, Dudley BS. Hainsworth JD, et al. Cancer Med. 2015 May;4(5):673-81. doi: 10.1002/cam4.376. Epub 2014 Dec 31. Cancer Med. 2015. PMID: 25556916 Free PMC article. Clinical Trial.
Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in COPD: A Cross-Sectional Observational Study.
MacLeod MA, Knott KD, Allinson JP, Finney LJ, Wiseman DJ, Ritchie AI, Braddy-Green A, Barlett-Pestell S, Lopez R, Sun L, Webb P, Dalal P, Rubens M, Davies S, Haskard DO, Devaraj A, Donaldson GC, Khamis RY, Nicol ED, Wedzicha JA. MacLeod MA, et al. Among authors: finney lj. Am J Respir Crit Care Med. 2024 Dec 16. doi: 10.1164/rccm.202404-0838OC. Online ahead of print. Am J Respir Crit Care Med. 2024. PMID: 39680915
Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease.
Finney LJ, Fenwick P, Kemp SV, Singanayagam A, Edwards MR, Belchamber KBR, Kebadze T, Regis E, Donaldson GD, Mallia P, Donnelly LE, Johnston SL, Wedzicha JA. Finney LJ, et al. Am J Physiol Lung Cell Mol Physiol. 2025 Jan 1;328(1):L120-L133. doi: 10.1152/ajplung.00118.2024. Epub 2024 Nov 19. Am J Physiol Lung Cell Mol Physiol. 2025. PMID: 39560620 Free article.
Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study.
Wiseman DJ, Thwaites RS, Ritchie AI, Finney L, Macleod M, Kamal F, Shahbakhti H, van Smoorenburg LH, Kerstjens HAM, Wildenbeest J, Öner D, Aerssens J, Berbers G, Schepp R, Uruchurtu A, Ditz B, Bont L, Allinson JP, van den Berge M, Donaldson GC, Openshaw PJM, Wedzicha J; RESCEU Investigators. Wiseman DJ, et al. Among authors: finney l. Am J Respir Crit Care Med. 2024 Oct 15;210(8):994-1001. doi: 10.1164/rccm.202308-1320OC. Am J Respir Crit Care Med. 2024. PMID: 38502541 Free PMC article.
136 results